CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $36,000 | -55.6% | 180,400 | 0.0% | 0.00% | – |
| Q3 2018 | $81,000 | -11.0% | 180,400 | 0.0% | 0.00% | – |
| Q2 2018 | $91,000 | -78.3% | 180,400 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $420,000 | -18.0% | 180,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $512,000 | -0.8% | 180,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $516,000 | +15.7% | 180,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $446,000 | -31.5% | 180,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $651,000 | -2.3% | 180,400 | -4.1% | 0.00% | 0.0% |
| Q4 2016 | $666,000 | -12.4% | 188,200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $760,000 | -13.9% | 188,200 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $883,000 | +12.6% | 201,100 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $784,000 | -77.3% | 207,400 | -5.7% | 0.00% | -80.0% |
| Q4 2015 | $3,448,000 | +48.7% | 219,900 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $2,318,000 | -58.2% | 219,900 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $5,546,000 | +6.4% | 219,900 | 0.0% | 0.01% | +14.3% |
| Q1 2015 | $5,214,000 | 0.0% | 219,900 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $5,214,000 | +82.9% | 219,900 | 0.0% | 0.01% | +75.0% |
| Q3 2014 | $2,850,000 | -20.6% | 219,900 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $3,589,000 | +3.0% | 219,900 | -1.7% | 0.01% | 0.0% |
| Q1 2014 | $3,483,000 | -42.2% | 223,700 | -10.7% | 0.01% | -44.4% |
| Q4 2013 | $6,021,000 | -25.2% | 250,555 | +10.3% | 0.01% | -40.0% |
| Q3 2013 | $8,050,000 | +164.0% | 227,220 | +16.3% | 0.02% | +150.0% |
| Q2 2013 | $3,049,000 | – | 195,354 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |